Final Program [International AIDS Society (11th: 1996: Vancouver, Canada)]

VENUE ROOM TRACK SESSION NO. TIME / SESSION PATHWAYS
S Bay 9 217 Track C: Epidemiology and Public Health
S- Exhibit Poster Discussion:
& Poster HIV Subtypes in Various Regions
Hall Moderators:
Mark Rayfield, USA / TT Smolskaya, Russia...............................................................................................................................................................................................................................................
Tu.C.220
HIV- I SUBTYPES IN FEMALE SEXUAL PARTNERS OF IDU AT THE SAO PAULO METROPOLITAN AREA
Brigido, Luis Fernando de Macedol/s, Rossini MI, Santos II, Camargo R2, Caesiro M3, Nunes D4, Duarte AJS4. IAdolfo Lutz Institute,
Retrovirus Laboratory, Brasilia;2AIDS Clinics of Sapopemba, Sapopemba; 3AIDS Clinics of Santos, Santos; 4Hospital das Clinicas, FMUSR
Sao Paulo; 5National STD/AIDS Program, Brasilia, Brazil................................................................................................................................................................................................................................................
Tu.C.221
MOLECULAR EPIDEMIOLOGY OF HIV-I SPREAD IN SOUTHEAST ASIA
Takebe,YutakaI, Kusagawa SI, Sato HI,Watanabe SI, Nohtomi K',Thwe M2, Ow KY2, Lwin S2, San K2, Kywe B2, Hien NG3,Thang BD3,
Long HT3,Yamazaki SI. 'National Institute of Health,Tokyo, Japan; 2Ministry of Health,Yangon, Myanmar; 3National Institute of Health
and Hygiene, Hanoi,Vietnam................................................................................................................................................................................................................................................
Tu.C.222
EPIDEMIOLOGY AND SUBTYPES OF HIV-I CIRCULATING IN NORTHWESTERN REGION OF RUSSIA
Smolskaya,TatyanaTI, Leinikki P2,Albert J3, Korovina G',Vlasov N', NovicovaV'. I'St. Petersburg Pasteur Institute, St. Petersburg, Russia;
2National Public Health Institute, Helsinki, Finland; 3Swedish Institute for Infectious Disease Control, Stockholm, Sweden................................................................................................................................................................................................................................................
Tu.C.223
PREVALENCE OF HIV-I SUBTYPE B IN BLOOD DONORS IN CHINA
Zhong, Ping', Fransen K2, Zhu WI, Duan JL', Liu GZ', Heyndrickx L2, Nkengason JN2, Leonaers A2, Lu QG, Ji WM', van der Groen G2,
Gou SQI. IShanghai Institute of Biological Products, Shanghai, PR China; 2lnstitute ofTropical Medicine, Antwerp, Belgium................................................................................................................................................................................................................................................
Tu.C.224
THE MOLECULAR EPIDEMIOLOGY OF HIV-I IN UGANDA.o Rayfield, Mark AI, Biryahwaho B2, Hu DI, Baggs ji, Luo CC', Downing R2, Carr LI, DelaTorre NI, Candal DI, Otten RAI, George JRI,
Schochetman GI, Dondero TJ i. iHIV LIB, DASTLR, CDC, Atlanta, GA, USA; 2Uganda Viral Research Institute, Entebbe, Uganda.
v )...............................................................................................................................................................................................................................................
g Tu.C.225
0
U HIV-I SUBTYPE D NEXT TO SUBTYPE C IS HIGHLY PREVALENT AMONG ETHIOPIAN RISK GROUPS
> Abebe, Almaz', Rinke de Wit TI, Messele TI, Sahlu T',Yeneneh HI, Fontanet A', Goudsmit J2, de Wolf F2. I Ethiopian Health & Nutrition
u Research Institute, Addis Ababa, Ethiopia; 2Dept. of Human Retrovirology, Academic Medical Center, University of Amsterdam,The
Netherlands.
C
0
a)
O
U
O
a)a)
o
0
U
C
0.C
aC
X

128